Hi Skitahoe,
One thing you should definitely look into is the twin clowns that many here don't want to accept. I have posted their history, along with 2 board members and they lack pretty much anything.
There are a lot of scenarios for this company. One of them is running out of cash before anything is approved. Yes ARS is the furthest advanced and pretty much the ONLY shot. Without it, chances are slim. They really only have phase 1 data on any of their trials outside ARS.
These clowns have missed deadline after deadline. Two damn years waiting for a partnership in Japan to get the "Fast track" started. We have about 24 hours for another failed partnership to happen...or another delay yet again. Will that make it 4 delays on the Sosei deal?
You want to invest, like Blue said its a gamble. But please take a look into management before you dive in blindly about the technology. Wish I did first. Many here don't care about management, but they truly are pathetic. Zero experience and that is the reason for eternal missed milestones. Experienced management would know the delays in pretty much everything. Zami's pharma experience is selling first aid kits for cars.
Their silence in pretty much everything, including holding any sort of CC ever, speaks volumes. Can't even update their only way to speak to shareholders, presentations. Or a Yaki fart at the Jerusalem Post conference. The street obviously has its doubts about this company. Hence our zero price appreciation for at least the last 7 years. But yet they gift themselves 2 million shares because they were sick of their options expiring worthless.
And let's not forget the uptick in the number of shows that occurred as soon as they got their PP.
24 hours to a major call for there heads. Except from the lemmings who belieb them. Many had given them until the end of the year that was supposed to be our year. But like always, that was delayed until 2018. Doesn't cut it for me. Can the incompetent twins ASAP. I'm hoping the Israeli investors they scammed in the latest pump lead the charge.
